Patent: 7,745,571
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 7,745,571
Title: | Peptide inhibitors of IASPP |
Abstract: | The invention relates to a polypeptide or part thereof which inhibits the apoptotic activity of the tumor suppressor protein p53, and includes screening methods to identify agents which interfere with the activity of the polypeptide. |
Inventor(s): | Lu; Xin (London, GB), Kuwabara; Patricia (Bristol, GB), Selwood; David (London, GB) |
Assignee: | Ludwig Institute for Cancer Research (New York, NY) Genome Research Limited (Cambridge, GB) UCL Cruciform Limited (Long, GB) |
Application Number: | 12/043,058 |
Patent Claims: | see list of patent claims |
Details for Patent 7,745,571
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | See Plans and Pricing | 2022-10-07 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |